Breast Carcinoma Clinical Trials in Kansas City, Kansas

3 studies are recruiting for breast carcinoma in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

    This phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese women who are at increased risk of developing breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works by blocking the e…

    Stage
    Phase 2
    Ages
    45 to 74
    Site
    University of Kansas Cancer Center, Kansas City, Kansas
    Locations
    3 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06195306 on ClinicalTrials.gov

  2. Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

    This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works …

    Stage
    Phase 2
    Ages
    18 to 55
    Site
    University of Kansas Cancer Center, Kansas City, Kansas
    Locations
    11 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06184750 on ClinicalTrials.gov

  3. Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

    This phase IIA trial compares the effect of acolbifene versus low dose tamoxifen in preventing breast cancer in premenopausal women at high risk for developing breast cancer. The usual approach for patients at increased risk for breast cancer is to undergo yearly breast magnetic resonance imaging o…

    Stage
    Phase 2
    Ages
    35 and older
    Site
    University of Kansas Cancer Center, Kansas City, Kansas
    Locations
    4 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05941520 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.